NCT02246075View on ClinicalTrials.gov

Study of the Safety of Two Doses of Investigational Study Drug EVP-6124 in Subjects With Alzheimer's Disease Currently Receiving Memantine

PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

July 31, 2015

Primary Completion Date

October 31, 2016

Conditions
Alzheimer's DiseaseDementiaCognition
Interventions
DRUG

EVP-6124

Trial Locations (2)

Unknown

Delray Beach

Albuquerque

Sponsors
All Listed Sponsors
collaborator

Quintiles, Inc.

INDUSTRY

lead

FORUM Pharmaceuticals Inc

INDUSTRY